Regeneron Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 695.42 USD | 818,9 USD | 538,658 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 819,253 USD | 14 | 5 | 5 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 103.021.886 | 3,53 | 3,6 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Regeneron Pharmaceuticals Inc
Mitarbeiter 15.343
Handelsplatz NASDAQ
Ticker Symbol REGN
IPO Datum 1991-04-02
Adresse 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707
Webseite https://www.regeneron.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman |
| 2 | Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
| 3 | Mr. Christopher R. Fenimore CPA | Executive VP of Finance & CFO |
| 4 | Mr. Joseph J. LaRosa J.D. | Executive VP, General Counsel & Secretary |
| 5 | Dr. Andrew J. Murphy Ph.D. | Executive VP of Research & Co-Chief Scientific Officer |
| 6 | Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply |
| 7 | Mr. Rajesh Ahuja | Senior Vice President of Quality Assurance & Operations |
| 8 | Mr. Ryan Steinberger | Executive VP, Chief Digital & Technology Officer |
| 9 | Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
| 10 | Ms. Melissa Lozner | Senior VP & Chief Compliance Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Dodge & Cox | 0,00% | 0,00 Mio. USD |
| 6 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 7 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 8 | Franklin Resources Inc | 0,00% | 0,00 Mio. USD |
| 9 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 11 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Loomis, Sayles & Company LP | 0,00% | 0,00 Mio. USD |
| 13 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 14 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 16 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 17 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 18 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 19 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 20 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |